
SynBioBeta 2026 Speaker
Barry Bunin
CDD
Founder & CEO
Barry A. Bunin, Ph.D. is the CEO of Collaborative Drug Discovery. Dr. Bunin has overseen $100 million in business transactions over the last two decades. CDD Vault hosts over 4 billion experimental SAR data points searched over 10 million times by scientists daily around the world doingโฆcollaborative drug discovery. Recent innovations include generative bioisosteres, ultrafast deep learning similarity search and chemically aware biologics capabilities (for example for each atom in ADCs).Prior to CDD, he was an Entrepreneur in Residence with Eli Lilly & Co. Dr. Bunin is on a patent for Kyprolisโข (Carfilzomib for Injection) โ a selective proteasome inhibitor that received accelerated FDA approval for the treatment of patients with multiple myeloma that was widely viewed as the centerpiece of Amgenโs $10.4 Billion acquisition of Onyx Pharmaceuticals.Dr. Bunin was the founding CEO, President, & CSO of Libraria (now Eidogen-Sertanty). At Libraria, he led a team that integrated exhaustive reaction capture (synthetic chemistry) with gene-family wide SAR capture (medicinal chemistry). In the lab, Dr. Bunin did medicinal synthetic chemistry developing patented new chemotypes for protease inhibition at Axys Pharmaceuticals (now Celera) and RGD mimics to inhibit GP-IIbIIIa at Genentech.Dr. Bunin received his B.A. from Columbia University and his Ph.D. from UC Berkeley, where he synthesized and tested the initial 1,4-benzodiazepine libraries with Professor Jonathan Ellman. On the scientific side, he co-authored 3 books: โChemoinformatics: Theory, Practice, and Productsโ (Springer-Verlag), a text that overviews modern chemoinformatics technologies, and โThe Combinatorial Indexโ (Academic Press), a widely used text on high-throughput chemical synthesis, and most recently self-published the collaborative book: โInside CDD Vault: A Different Kind of Silicon Valley Success Story (Behind the Code: The Human Side of Collaborative Drug Discovery)โ available on Amazon.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


